Long-term retreatment in chronic hepatitis C patients who were non-responders to an initial course of interferon-α2b

Journal of Viral Hepatitis

Volumn 5, Issue 5, 1998, Pages 323-331

  Tong, M J ^a   Blatt, L M ^b   Tong, L T ^a   Sayadzadeh, K ^a   Conrad, A ^b  

^a HUNTINGTON MEMORIAL HOSPITAL   (United States)

^b National Genetics Institute   (United States)

Author keywords

Chronic hepatitis C; Interferon; Non responders; Retreatment

Indexed keywords

ALPHA2B INTERFERON; VIRUS RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CIRRHOSIS; LONG TERM CARE; MALE; PRIORITY JOURNAL; RETREATMENT; VIRUS TYPING;

ADULT; AGED; ANTIVIRAL AGENTS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, VIRAL; TIME FACTORS;

EID: 0031713565     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1998.00120.x     Document Type: Article

References (20)

1. Hoofnagle JH, Mullen KD, Jones DB et al. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report. N Engl J Med 1986; 315: 1575-1578.
2. Davis G, Balart LA, Schiff ER et al. The hepatitis interventional therapy group. Treatment of chronic hepatitis with recombinant interferon alpha. A multicenter randomized, controlled trial. N Engl J Med 1989; 321: 1501-1506.
3. Marcellin P, Boyer N, Giostra E et al. Recombinant human (alpha) interferon in patients with chronic non-A and non-B hepatitis: A multicenter randomized controlled trial from France. Hepatology 1991; 12: 393-397.
4. Causse X, Godinot H, Chevallier M et al. Comparison of 1 or 3 MU of interferon alpha-2b and placebo in patients with chronic non-A, non-B hepatitis. Gastroenterology 1991; 101: 497-502.
5. Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997; 336: 347-356.
6. Blatt LM, Tong MJ, McHutchison JG, Russell J, Schmid P, Conrad A. Discordance between serum alanine amino transferase (ALT) and virologic response to interferon alpha-2b in chronic hepatitis C patients with high and low pretreatment serum hepatitis C virus RNA titers. J Interferon Cytokine Res 1998; 18: 75-80.
7. Tong MJ, Blatt LM, Conrad A et al. The changes in quantitative HCV-RNA titers during interferon alpha 2B therapy inpatients with chronic hepatitis C infection. J Gastroenterol 1998; 93: 601-605.
8. Tong M, Hwang SJ, Lefkowitch M et al. Correlation of serum HCV RNA and alanine amino transferase levels in chronic hepatitis C patients during treatment with Ribavirin. J Gastroenterol Hepatol 1994; 9: 587-591.
9. Tong M, Blatt L, McHutchison JG, Co RL, Conrad A. Prediction of response during interferon alpha-2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison. Hepatology 1997; 26: 1640-1645.
10. Friis RH, Stellers TA. Epidemiology for Public Health Practice. Gaithersburg, Maryland: Aspen Publications, 1996.
11. Pardo M, Cotonat T, Herrero M et al. Retreatment of chronic hepatitis C virus infection. Lancet 1994; 343: 1568-1569.
12. Marcellin P, Boyer N, Pouteau M, Benhamou JP, Erlinger S. Retreatment with Interferon alpha-2b of chronic hepatitis C infection. Lancet 1994; 344: 690-691.
13. Chow WC, Marcellin P, Boyer N et al. Interferon retreatment in chronic hepatitis C (CHC) patients after a standard course of interferon therapy. Hepatology 1996; 24: 274A.
14. Rabinovitz M, Block G, Finkelstein S. Alpha-2b interferon retreatment of patients with chronic hepatitis C. Am J Gastroenterol 1996; 91: 1523-1526.
15. Heathcote J, Keeffe E, Lee S et al. and the consensus interferon study group. Retreatment of chronic hepatitis C with consensus interferon. Hepatology 1998; 27: 1136-1143.
16. Picciotto A, Brizzolara R, Campo N et al. Two year interferon retreatment may induce a sustained response in relapsing patients with chronic hepatitis C. Hepatology 1996; 24: 273A.
17. Payen JL, Izopet J, Galindo V, Barange K, Puel J, Pascal JP et le groupe d'etude et de trait'ment du virus de l'hepetite C. A comparison of three interferon alfa-2b regimens for treatment (RTT) of patients with chronic hepatitis C with prior complete response followed by relapse; a controlled randomized trial. Hepatology 1996; 24: 273A.
18. Bresci G, Parisi G, Banti S, Capzia A. Retreatment of interferon-resistant patients with chronic hepatitis C with interferon-alpha-2b. J Viral Hep 1995; 2: 155-158.
19. Toyoda H, Nakano S, Takeda I et al. Retreatment of chronic hepatitis C with interferon. Am J Gastroenterol 1994; 89: 1453-1457.
20. Everson G, Craig JR, Jensen D, Van Leeuwen DJ and the consensus interferon study group. Cirrhotic patients demonstrate similar response pattern compared to non-cirrhotic patients when treated with consensus interferon. Hepatology 1997; 26: 422A.